King J R, Peters B P, Monteiro-Riviere N A
Cutaneous Pharmacology and Toxicology Center, College of Veterinary Medicine, North Carolina State University, Raleigh 27606.
Toxicol Appl Pharmacol. 1994 May;126(1):164-73. doi: 10.1006/taap.1994.1103.
The epidermal-dermal junction has a complex molecular architecture, with numerous components playing key roles in adhesion of the epidermis to the dermis. The purpose of this study was to examine structural components of the epidermal-dermal junction as potential targets for toxicity by lewisite (dichloro(2-chlorovinyl)arsine). This was accomplished by (1) immunocytochemical mapping of laminin, type IV collagen, and bullous pemphigoid antigen (BPA) in lewisite-treated isolated perfused porcine skin flaps (IPPSF), (2) evaluation of protease activity in IPPSF blister fluid against laminin substrate from murine EHS tumor and human keratinocytes, and (3) examination of human keratinocyte laminin for direct chemical modification by lewisite. Lewisite-induced epidermal-dermal separation was localized to the lamina lucida. Localization of the separation suggested that laminin, a cysteine-rich and highly protease-sensitive adhesive glycoprotein, is a potential target for lewisite action. It was hypothesized that chemical modification of laminin directly (via chemical alkylation of laminin thiols by the arsenical) or indirectly (due to lewisite-induced cytotoxic release of proteases) could result in blister formation. Employing sensitive methodology, no evidence of proteolytic activity against EHS tumor laminin or human keratinocyte laminin was identified in the blister fluid. In addition, no evidence for direct chemical modification of laminin by lewisite was demonstrated. However, up to 36% of the thiol groups in human keratinocyte laminin immunoprecipitates was potentially available for reaction with alkylating agents. While these studies did not demonstrate a lewisite-induced chemical modification of laminin, they do not rule out the possibility that other adhesive molecules of the basement membrane are targets for lewisite action. Further evaluation of the molecular role that these binding modalities play in vesicant-induced separation may provide new insights into therapeutic and prophylactic strategies against the toxicity of such compounds and contribute to a better understanding of basement membrane biochemistry.
表皮 - 真皮连接具有复杂的分子结构,众多成分在表皮与真皮的黏附中发挥关键作用。本研究的目的是检查表皮 - 真皮连接的结构成分作为路易氏剂(二氯(2 - 氯乙烯基)胂)毒性作用的潜在靶点。这通过以下方式实现:(1)对经路易氏剂处理的离体灌注猪皮瓣(IPPSF)中的层粘连蛋白、IV型胶原蛋白和大疱性类天疱疮抗原(BPA)进行免疫细胞化学定位;(2)评估IPPSF水疱液中针对来自小鼠EHS肿瘤和人角质形成细胞的层粘连蛋白底物的蛋白酶活性;(3)检查人角质形成细胞层粘连蛋白是否被路易氏剂直接化学修饰。路易氏剂诱导的表皮 - 真皮分离定位于透明层。分离的定位表明,层粘连蛋白是一种富含半胱氨酸且对蛋白酶高度敏感的黏附糖蛋白,是路易氏剂作用的潜在靶点。据推测,层粘连蛋白的直接化学修饰(通过胂对层粘连蛋白硫醇的化学烷基化)或间接修饰(由于路易氏剂诱导的蛋白酶细胞毒性释放)可能导致水疱形成。采用灵敏的方法,在水疱液中未发现针对EHS肿瘤层粘连蛋白或人角质形成细胞层粘连蛋白的蛋白水解活性证据。此外,未证明路易氏剂对层粘连蛋白有直接化学修饰。然而,人角质形成细胞层粘连蛋白免疫沉淀物中高达36%的硫醇基团可能可与烷基化剂反应。虽然这些研究未证明路易氏剂对层粘连蛋白有化学修饰,但它们并不排除基底膜的其他黏附分子是路易氏剂作用靶点的可能性。对这些结合方式在糜烂性毒剂诱导分离中所起分子作用的进一步评估,可能为针对此类化合物毒性的治疗和预防策略提供新见解,并有助于更好地理解基底膜生物化学。